Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 7Colorectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplastic Syndromes, Hereditary 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Tuberous Sclerosis 1Thyroid Neoplasms 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Primary Ovarian Insufficiency 1Polycystic Ovary Syndrome 1Pheochromocytoma 1Pediatric Solid Tumor 1Paraganglioma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms, Unknown Primary 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoproliferative Disorders 1Lymphangioleiomyomatosis 1Lipodystrophy, Familial Partial 1Kidney Neoplasms 1Histiocytosis, Non-Langerhans-Cell 1

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Biopsy 5ulixertinib 2trametinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2dabrafenib 2LY3023414 2olaparib 1etoposide phosphate 1cobimetinib 1Vemurafenib 1Sirolimus 1Pharmacogenomic Variants 1Lenalidomide 1Genetic Testing 1Etoposide 1Cyclophosphamide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis, Langerhans-Cell × Genetic Testing × 1 year × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡